ENT |
INTEREDIATE NAME |
CAS NUMBER |
INTERNAL CODE |
Anti Ulcer |
Ranitidine HCl Intermediates |
2-[[[5-(dimethylamino) methyl-1,2-furanyl] methyl] thio] ethanamine |
66356-53-4 |
CYF-P |
(or) |
2-((5-((dimethylamino)methyl)furan-2- yl)methylthio)ethanamine |
N-methyl-1-(methylthio)-2-nitroethenamine. |
61832-41-5 |
NMSW |
N-[2-[[[5-(dimethylamino) methyl] furan-2-yl] methyl] thio] ethyl]-N-methyl-2-nitroethene-1,1-diamine |
66357-35-5 |
RB |
Famotidine Intermediates |
2- [4-(chloromethyl) thiazol-2-yl] guanidine hydrochloride |
69014-12-6 |
FMT-I |
N-[4-[[(amino iminomethyl) thio]-methyl]-2-thiazolyl]-guanidine dihydrochloride |
88046-01-9 |
FMT-II |
Sulfuric diamide |
7803-58-9 |
Sulfamide |
N-Sulfamyl-3-chloro propionamidine HCl |
106649-95-0 |
IFM |
Aminoiminoethyl thiourea |
05-02-2114 |
GTU |
1,3 -Dichloro acetone |
534-07-6 |
DCA |
Anti Migraine |
Rizatriptan Intermediates |
1-(4-Nitrophenyl)methyl-1,2,4-triazole |
119192-09-5 |
RTZ-II |
4-(1H-1,2,4-Triazol-1-ylmethyl)aniline |
119192-10-8 |
RTZ-III |
Eletriptan HBr Intermediates |
(3- [(R)-1-(Benzyloxy) carbonyl pyrrolidine -2-carbonyl) -5-bromoindole |
[143322-56-9] |
ETN-II |
5-Bromo-3-(((R)-1-methylpyrrolidin-2-yl) methyl)-1H-indole |
[143322-57-0] |
ETN-III |
Phenyl vinyl sulfone |
[5535-48-8] |
ETNSC |
Zolmitriptan intermdiate |
Methyl (S)-N-ethoxycarbonyl-4-nitrophenylalaninate |
|
ZMT-IIA |
Anti Hypertensive |
Imidapril Intermediates |
N-Benzyloxycarbonyl-L-aspargine |
2304-96-3 |
IPL-I |
Tert-Butyl-(4S)-3-(benzyloxycarbonyl)-2-oxoimidazolidine-4-carboxylate |
[77999-24-7] |
IPL-III |
Tert-Butyl-(4S)-1-methyl-2-oxoimidazolidine-4-carboxylate |
[83056-79-5] |
IPL-V |
Perindopril Intermediate |
N-[(S)-1-Carbethoxybutyl]-(S)-alanine |
82834-12-6 |
CEA-II |
Erectile Dysfunction |
Sildenafil Intermediates |
5-(2-Ethoxyphenyl)-1-methyl-3-propyl-1H-pyrazolo [4,3-d] pyrimidine-7 (6H)-one |
139756-21-1 |
SLC-IV |
1-[[3-(4,7 dihydro-1-methyl-7-oxo 3-propyl-1-H pyrazole [4,3-d] pyrimidin-5 yl)-4-ethoxy phenyl]sulphonyl-4-methyl piperazine] |
139755-83-2 |
SLC-V |
5-(5-Chlorosulfonyl-2-ethoxyphenyl)1-methyl-3-n-propyl-1,6-dihydro-7H-pyrazolo-(4,3-d)pyrimidin-7-one |
139756-22-2 |
SLC-Chlorosulfonyl |
4 amino-1- methyl- 3- propyl-1h- pyrzaole- 5 – carboxamide |
139756-02-8 |
SLC-AMENE |
1-Methyl-4-nitro-3-propyl-1H-pyrazole-5-carboxamide |
139756-01-7 |
SLC-III |
Anti Cancer |
Imatinib Intermediates |
N-(2-Methyl-5-Nitrophenyl)-4-(3-pyridyl)-2-pyrimidinamine |
[152460-09-8] |
OTD-III |
N-(5-Amino-2-Methylphenyl)-4-(3-Pyridyl)-2-Pyrimidinamine |
[152460-10-1] |
OTD-IV |
4-(4-methyl piperazinomethyl) benzoic acid dihydrochloride |
[106261-49-8] |
PATA-III |
Antifungal |
Itraconazole Intermediates |
cis-2-[(2,4-dichlorophenyl)-2-(1H-1,2,4,triazol-1-ylmethyl)1,3dioxolan-4yl]-methyl- methane sulphonate (IT-IB) |
67914-86-7 |
IT -IB |
2,4-dihydro-4-(4-[4-(4-methoxyphenyl)-1-piperazinyl]phenyl)-2-(1-methyl propyl)-3H-1,2,4-triazole-3-one(IT-VII) |
252964-68-4 |
IT -VII |
2,4-dihydro-4-[4-[4-[4-hydroxy phenyl]-1-piperazinyl phenyl]-2-(1-methyl propyl)-3H-1,2,4-triazol-3-one (IT-VIII) |
106461-41-0 |
IT -VIII |
Cis-2-(bromo methyl)-2-(2,4-dichlorophenyl)-4-methane sulphonyl methyl-1,3-dioxolane.(CBM) |
82966-34-5 |
CBM |
Anti ulcer |
Pantoprazole Intermediates |
4-chloro-3-methoxy-2-methyl pyridine |
107512-34-5 |
PZL-III |
2 - chloromethyl - 3,4 - dimethoxy pyridine HCl |
72830-09-2 |
PPL-I |
N-(4-(difluoromethoxy)phenyl)acetamide |
[22236-11-9] |
BZL-I |
4-(difluoromethoxy)-2-nitrobenzenamine |
[97963-76-3] |
BZL-II |
4-(DIfluoromethoxy) benzene-1,2-diamine |
172282-50-7 |
BZL-III |
Anti obesity |
Sibutramine Hcl intermediates |
1-(1-(4-chlorophenyl) cyclo butane carbonitrile |
28049-61-8 |
SBM-I |
1-(1-(4-chlorophenyl)cyclobutyl)-3-methylbutan-1-amine hydro chloride |
84484-78-6 |
SBM-V salt |
Anti Emetic |
Domperidone Intermediates |
Ethyl 4-aminopiperidine-1-carboxyalte |
58859-46-4 |
DOM-I |
Ethyl-4-((4-chloro-2-nitrophenyl)amino) piperidine 1-carboxylate |
53786-44-0 |
DOM-II |
Ethyl-4-[(2-amino-4-chlorophenyl)amino]piperidine-1-carboxylate |
53786-45-1 |
DOM-III |
5-Chloro 1,3-dihydro-1-(4-piperidinyl)-2H-Benzimidazol-2-one |
53786-28-0 |
DOM-IV |
1-(prop-1-en-2-yl)-1H-benzo[d]imidazol-2(3H)-one |
52099-72-6 |
CPB-I |
1-(3-chloropropyl)-1H-benzo[d]imidazol-2(3H)-one |
62780-89-6 |
CPB-II |
Anti Depressant |
Mirtazapine intermediates |
Isopropyl 2-chloronicotinate |
|
MZA-I |
(2-(4-methyl-2-phenylpiperazin-1-yl)pyridin-3-yl)methanol |
61337-89-1 |
MZA-II |
Anti Worm |
Albendazole intermediates |
2-nitro-4-(propylthio)aniline |
54393-89-4 |
ABZ-I |
4-(propylthio)benzene-1,2-diamine |
66608-52-4 |
ABZ-II |
Anti Gout |
Allopurinol intermediates |
2-cyano-3-(dimethyl amino) acrylamide |
37858-68-7 |
ALP-I |
5-amino-1H-pyrazole-4-carboxamide hemisulphate |
27511-79-1 |
ALP-II |
Anti Infective |
Dapsone intermediate |
4,4’sulfonyldianiline |
80-08-0 |
DPN-I |
Anti Convulsant |
Fosphenytion Intermediates |
2,4-imidazolidinedione-5,5-diphenyl-3-hydroxymethyl |
NA |
FPS-I |
2,4-imidazolidinedione-5,5-diphenyl-3-chloromethyl |
NA |
FPS-II |
Silver Dibenzyl Phosphate |
50651-75-7 |
FPS-IIIA |
2,4-imidazolidinedione-5,5-diphenyl-3-hydroxymethyl-dibenzyloxy phosphate |
NA |
FPS-III |
2,4-imidazolidinedione,5,5-diphenyl-3-[(phosphonooxy)methyl]-disodium salt |
NA |
FPS-IV |
Antiviral |
Peramivir Intermediates |
Methyl (1S,4R)-4-aminocyclopent-2-ene-1-carboxylate (2R,3R)-2,3-dihydroxysuccinate |
419563-22-7 |
PMV-I |
Methyl (1S,4R)-4-((tert-butoxycarbonyl) amino) cyclopent-2-ene-1-carboxylate |
168683-02-1 |
PMV-II |
Methyl (1S,2S,3S,4R)-3-((S)-1-amino-2-ethylbutyl)-4-((tert-butoxycarbonyl) amino)-2-hydroxycyclopentane-1-carboxylate |
316173-29-2 |
PMV-III |
Anesthesia |
Ropivacaine HCl Intermediates |
(S)-N-(2,6-dimethylphenyl)piperidine-2-carboxamide hydrochloride |
65797-42-4 |
RPH-I |
(S)-N-(2,6-dimethylphenyl)-1-propylpiperidine-2-carboxamide |
84057-95-4 |
RPH-II |
(S)-N-(2,6-dimethylphenyl)-1-propylpiperidine-2-carboxamide hydrochloride monohydrate |
132112-35-7 |
RPH-III |
All Transactions are carried out in conformity with patent laws applicable in the user country. Responsibility with respect to third party's patent right in a specific country lies exclusively with the buyer. |